Received Feb 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | — |
Felt Horrible; This non-serious case was reported by a consumer via call center representative and described the occurrence of feels awful in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced feels awful (Verbatim: Felt Horrible). The outcome of the feels awful was unknown. It was unknown if the reporter considered the feels awful to be related to Shingrix. It was unknown if the company considered the feels awful to be related to Shingrix. Additional Information: GSK Receipt Date: 07-FEB-2025 This case was reported by patient itself. The patient felt horrible after receiving Shingrix. The patient could not elaborate on what she experienced as she could not remember but remembers only that she felt horrible. The patient could not remember when the first dose was given, but was schedule for the second dose on this day (07-February-2025).